Results for Mitochondrial Biology

This week’s roundup features research reinforcing the need for better universal surveillance for developmental delays and increased access to early intervention. This and more In The News.

The findings reveal new clues about the disease’s underlying biology

Knowing the causative genes for osteoporosis may later open the door to more effective treatments. Research by Struan Grant, PhD, and Andrew Wells, PhD.

New preclinical findings from extensive cell and animal studies suggest that a drug already used for a rare kidney disease could benefit patients with some mitochondrial disorders—complex conditions with severe energy deficiency for which no proven effective treatments exist. Future clinical research is needed to explore whether the drug, cysteamine bitartrate, will meaningfully benefit patients.

CHOP Researchers: Patient-Centric Perspective Offers Key Insights into Upcoming Treatment Studies

This week in research news: teasing out genetic clues across the skeleton, a "missing mutation" in infant epilepsy, and studying soy-based baby formulas.

CHOP Researchers Co-Author Expert Review of Nutritional Interventions

The last two weeks of 2017 were packed with exciting news for children's health. Catch up in our latest roundup of research headlines.

From new insights into brain tumor biology to building a network for pediatric trials, don't miss this week's research roundup.